Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes
Vergleich von Surrogatindizes für Insulinresistenz als Prädiktoren für Typ-2-Diabetes
The Journal of Clinical Endocrinology & Metabolism · 15.07.2026 · 111 (8) · 2251-2261
DOI: 10.1210/clinem/dgag101 ↗Auf einen Blick
Bei 2.260 indigenen Amerikaner:innen sagten OGTT-basierte Surrogatindizes Typ-2-Diabetes am besten voraus. Ohne Insulinmessung schnitt METS-IR am besten ab.
Fragestellung
Welche von 18 Surrogatindizes für Insulinresistenz sagen Typ-2-Diabetes am besten voraus?
Methode
Kohortenstudie bei indigenen Amerikaner:innen aus dem Südwesten der USA; Vergleich von 18 Indizes; Follow-up bis 14,5 Jahre.
Ergebnisse
2.260 Personen, 509 Fälle von Typ-2-Diabetes. Matsuda hatte das höchste r mit M (0,691); Gutt und Cederholm die höchsten AUCs (0,728 und 0,728).
Schlussfolgerung der Autor:innen
Laut den Autor:innen sind auf OGTT basierende Surrogatmaße am besten zur Vorhersage von Typ-2-Diabetes geeignet; Nüchterninsulin-basierte Maße schneiden besser ab als solche ohne Insulinmessung.
Kernaussagen
- OGTT-basierte Indizes sagten Typ-2-Diabetes am besten voraus.
- Matsuda hatte das höchste r mit der Insulinsensitivität M (0,691).
- METS-IR hatte unter den nicht-insulinbasierten Indizes die höchste AUC (0,688).
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 10.03.2026. Verfasst von Laura Vazquez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, P…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance, Biomarkers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, NIDDK NIH HHS, NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Decreased insulin sensitivity (insulin resistance) is associated with increased type 2 diabetes (T2D) risk. Identifying reliable surrogate indexes that use standard clinical assays might improve the prevention of T2D.
Objective
The objective was to compare the ability of 18 surrogate indexes of insulin resistance to predict T2D.
Design
Cohort study of indigenous Americans from the southwest United States.
Setting
Community-based longitudinal study. Patients and Other Participants We studied T2D risk in 2260 people followed for up to 14.5 years (509 cases of T2D). We estimated correlation coefficients (r) of all indexes with sensitivity (M) measured by hyperinsulinemic–euglycemic clamp in 286 persons. We calculated indexes obtained from oral glucose tolerance tests (OGTTs) using fasting and 2-hour glucose and insulin measures.
Interventions
None. Main Outcome Measures Predictive performance was assessed by the hazard ratio per SD and by the area under the receiver operating curve (AUC).
Results
Indexes calculated from OGTTs performed best; Matsuda had the highest r with M (0.691); Gutt and Cederholm had the highest AUCs (0.728 and 0.728, P < .05 compared with all other indexes). In indexes that only used fasting insulin levels, the quantitative insulin sensitivity check index and Homeostatic Model for Insulin Resistance had the best performance with equal r (0.644) and AUC (0.701). Among indexes that did not require insulin measurement, the metabolic score for insulin resistance (METS-IR) and single-point insulin sensitivity index had the highest r (0.597 and 0.595), while METS-IR had the highest AUC (0.688).
Conclusion
Surrogate measures based on OGTTs are best for predicting T2D, while measures based on fasting insulin perform better than those that do not measure insulin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85004, USA.
ORCID-Profile: Robert L Hanson
Förderung
- Intramural NIH HHS
- NIDDK NIH HHS
- NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
Zitieren
APA
Vazquez, L., Vazquez Arreola, E., Nagul, M., Krakoff, J., & Hanson, R. L. (2026). Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism, 111(8), 2251-2261. https://doi.org/10.1210/clinem/dgag101
Vancouver
Vazquez L, Vazquez Arreola E, Nagul M, Krakoff J, Hanson RL. Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026;111(8):2251-2261. doi:10.1210/clinem/dgag101
BibTeX
@article{Vazquez2026,
author = {Vazquez, Laura and Vazquez Arreola, Elsa and Nagul, Murugasu and Krakoff, Jonathan and Hanson, Robert L},
title = {Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {8},
pages = {2251--2261},
doi = {10.1210/clinem/dgag101}
}
EUVIMED